EUVIMEDEUVIMED entdecken
Crossref

Retrospective application of WHO reporting system for lung cytopathology with assessment of risk of malignancy

Rachana Meena, Aruna Nambirajan, Anant Mohan, Prabhat Singh Malik, Deepali Jain

Journal of the American Society of Cytopathology · 2024

DOI: 10.1016/j.jasc.2024.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Cytopathology, 2024. Verfasst von Rachana Meena und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Lung Neoplasms, World Health Organization. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The recently introduced World Health Organization (WHO) Reporting System for Lung Cytopathology presents 5 diagnostic categories with corresponding risk of malignancy (ROM) and management protocols. This study uses the system to categorize our institutional respiratory tract cytology specimens, evaluating ROM and diagnostic accuracy for each category. MATERIALS AND METHODS: In a retrospective analysis (May 2020 to August 2021), the following respiratory cytology specimens were classified based on the WHO categories: bronchoalveolar lavage (BAL), bronchial wash/bronchial brushings (BB/BW), endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), fine-needle aspiration cytology (FNAC), sputum, biopsy imprint (BI), and endotracheal wash. Exclusions comprised pleural effusions and EBUS-TBNA from mediastinal and hilar lymph nodes. Correlation of cytologic and histopathologic diagnoses was performed to assess ROM collectively and individually. RESULTS: A total of 1518 respiratory samples (BAL [968], BW/BB [380], EBUS-TBNA [42], FNAC [32], sputum [80], BI [11] and endotracheal wash [5]) of 1410 patients were screened, of which 522 cases (34.3%) had histopathologic correlation. One hundred forty-one cases (9.3%) were Insufficient/Inadequate/Non-Diagnostic (ND), 1221 (80.4%) were Benign (B), 3 (0.2%) were Atypical (A), 32 (2.1%) were Suspicious for malignancy (SM) and 121 (8.0%) were Malignant (M). The estimated ROM for each category was 49.2% for ND, 13.3% for B, 66.6% for A, 81.5% for SM and 92.7% for M. FNAC and EBUS-TBNA exhibited the highest sensitivity (100%) compared with BW/BB (66.3%). Specificity ranged from 96.8% to 100% across the samples, while diagnostic accuracy varied from 58.8% to 100%. CONCLUSIONS: Application of the WHO reporting system enhances standardized terminology, aiding clinicians in informed decision-making and improving patient care through accurate risk assessment of malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsWorld Health OrganizationAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedBronchoalveolar Lavage FluidCytodiagnosisEndoscopic Ultrasound-Guided Fine Needle AspirationLungRetrospective StudiesRisk AssessmentSputum

Stichwörter der Autor:innen

CytologyDiagnostic categoriesLungRespiratory tractRisk of malignancyWHO reporting system for lung cytopathology

Autor:innen und Institutionen

  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pulmonary Medicine and Critical Care Unit, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Medical Oncology, Dr B.R.A Institute Rotary Cancer Hospital, New Delhi, India.
  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: deepalijain76@aiims.edu.

Zitieren

APA

Meena, R., Nambirajan, A., Mohan, A., Malik, P. S., & Jain, D. (2024). Retrospective application of WHO reporting system for lung cytopathology with assessment of risk of malignancy. Journal of the American Society of Cytopathology. https://doi.org/10.1016/j.jasc.2024.02.003

Vancouver

Meena R, Nambirajan A, Mohan A, Malik PS, Jain D. Retrospective application of WHO reporting system for lung cytopathology with assessment of risk of malignancy. Journal of the American Society of Cytopathology. 2024. doi:10.1016/j.jasc.2024.02.003

BibTeX
@article{Meena2024,
  author = {Meena, Rachana and Nambirajan, Aruna and Mohan, Anant and Malik, Prabhat Singh and Jain, Deepali},
  title = {Retrospective application of WHO reporting system for lung cytopathology with assessment of risk of malignancy},
  journal = {Journal of the American Society of Cytopathology},
  year = {2024},
  doi = {10.1016/j.jasc.2024.02.003}
}
Kostenlos starten →